TrialGeneral thoracic and cardiovascular surgery2025

The effect of spironolactone in reducing the risk of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: randomized single-blind placebo-controlled study.

Ava Farzaneh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.